BATS BZX Real-Time Price
As of 2:45pm ET
| -0.10 / -3.11%|
The 6 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 11.00, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +252.56% increase from the last price of 3.12.
The current consensus among 8 polled investment analysts is to Buy stock in Regulus Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.